TVRD

insider transactions

Tvardi Therapeutics, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 9, 26

Michael S Wyzga

Director

$0

6.0K sh

Own New
Grant·A
Jun 9, 26

Cynthia Smith

Director

$0

6.0K sh

Own New
Grant·A
Jun 9, 26

Susan Shiff Ph.D.

Director

$0

6.0K sh

Own New
Grant·A
Jun 9, 26

Sujal Shah

Director

$0

6.0K sh

Own New
Grant·A
Jun 9, 26

Wallace L Hall JR

Director

$0

6.0K sh

Own New
Grant·A
Jan 29, 26

Stephen Paul O'Brien

Principal Accounting Officer

$0

15.0K sh

Own New
Grant·A
Jan 29, 26

John Saewook Kauh M.D.

Chief Medical Officer

$0

45.0K sh

Own New
Grant·A
Jan 29, 26

Avi Daniel Conn KEY

Chief Financial Officer

$0

45.0K sh

Own New
Grant·A
Jan 29, 26

Imran Nizamudin Alibhai KEY

Chief Executive Officer

$0

115.0K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 9, 2026	Michael S Wyzga	Director	Grant A	6.0K	New	—	$0
Jun 9, 2026	Cynthia Smith	Director	Grant A	6.0K	New	—	$0
Jun 9, 2026	Susan Shiff Ph.D.	Director	Grant A	6.0K	New	—	$0
Jun 9, 2026	Sujal Shah	Director	Grant A	6.0K	New	—	$0
Jun 9, 2026	Wallace L Hall JR	Director	Grant A	6.0K	New	—	$0
Jan 29, 2026	Stephen Paul O'Brien	Principal Accounting Officer	Grant A	15.0K	New	—	$0
Jan 29, 2026	John Saewook Kauh M.D.	Chief Medical Officer	Grant A	45.0K	New	—	$0
Jan 29, 2026	Avi Daniel Conn KEY	Chief Financial Officer	Grant A	45.0K	New	—	$0
Jan 29, 2026	Imran Nizamudin Alibhai KEY	Chief Executive Officer	Grant A	115.0K	New	—	$0

About TVRD insider trading

This page tracks insider transactions for Tvardi Therapeutics, Inc. (TVRD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.